SCHEMBL4547747

SCHEMBL4547747

O=CC(O)COP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3856157 1.00
SCHEMBL3876725 0.74
SCHEMBL12510665 0.74
SCHEMBL13635951 0.72
SCHEMBL7823415 0.69
SCHEMBL6279266 0.69
SCHEMBL10289798 0.69 AKR1B1 (0.42)
SCHEMBL16373412 0.69
SCHEMBL6288609 0.69 MAPK1 (0.54)
SCHEMBL10056679 0.69 AKR1B1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140162900-A1 METHOD FOR HIGH-THROUGHPUT SCREENING OF COMPOUNDS AND COMBINATIONS OF COMPOUNDS FOR DISCOVERY AND QUANTIFICATION OF ACTIONS, PARTICULARLY UNANTICIPATED THERAPEUTIC OR TOXIC ACTIONS, IN BIOLOGICAL SYSTEMS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-06-12 US disclosed
US-8401800-B2 Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-03-19 US disclosed
US-20120115127-A1 MOLECULAR FLUX RATES THROUGH CRITICAL PATHWAYS MEASURED BY STABLE ISOTOPE LABELING IN VIVO, AS BIOMARKERS OF DRUG ACTION AND DISEASE ACTIVITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-05-10 US disclosed